Toth Financial Advisory Corp Has $237,000 Stake in Unum Group (NYSE:UNM)

Toth Financial Advisory Corp trimmed its position in shares of Unum Group (NYSE:UNM) by 6.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,250 shares of the financial services provider’s stock after selling 228 shares during the period. Toth Financial Advisory Corp’s holdings in Unum Group were worth $237,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Capital Performance Advisors LLP bought a new stake in Unum Group during the 3rd quarter valued at approximately $31,000. Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Unum Group in the third quarter valued at approximately $37,000. V Square Quantitative Management LLC boosted its position in shares of Unum Group by 38.2% in the third quarter. V Square Quantitative Management LLC now owns 702 shares of the financial services provider’s stock valued at $42,000 after acquiring an additional 194 shares during the period. Versant Capital Management Inc grew its stake in shares of Unum Group by 26.4% in the fourth quarter. Versant Capital Management Inc now owns 766 shares of the financial services provider’s stock worth $56,000 after acquiring an additional 160 shares during the last quarter. Finally, William B. Walkup & Associates Inc. bought a new position in Unum Group during the second quarter worth $44,000. 86.57% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on UNM. BMO Capital Markets started coverage on shares of Unum Group in a report on Thursday. They issued an “outperform” rating and a $91.00 price target for the company. Barclays lifted their target price on Unum Group from $76.00 to $85.00 and gave the stock an “overweight” rating in a research report on Monday, January 6th. Piper Sandler upped their price target on Unum Group from $74.00 to $82.00 and gave the company an “overweight” rating in a report on Wednesday, December 18th. Jefferies Financial Group raised their price objective on Unum Group from $91.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, December 10th. Finally, Bank of America boosted their price objective on Unum Group from $54.00 to $63.00 and gave the company a “neutral” rating in a research report on Thursday, October 10th. Five investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $76.75.

Insider Activity

In other Unum Group news, CEO Richard P. Mckenney sold 58,865 shares of the company’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $75.39, for a total transaction of $4,437,832.35. Following the transaction, the chief executive officer now owns 1,007,003 shares of the company’s stock, valued at approximately $75,917,956.17. This represents a 5.52 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Elizabeth Claire Ahmed sold 5,000 shares of Unum Group stock in a transaction on Thursday, October 31st. The shares were sold at an average price of $64.16, for a total value of $320,800.00. Following the completion of the sale, the executive vice president now directly owns 58,741 shares of the company’s stock, valued at $3,768,822.56. This trade represents a 7.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 107,914 shares of company stock worth $7,998,745. 0.93% of the stock is owned by corporate insiders.

Unum Group Trading Down 0.7 %

Shares of Unum Group stock opened at $75.01 on Friday. Unum Group has a 12-month low of $46.39 and a 12-month high of $77.63. The stock has a market capitalization of $13.70 billion, a P/E ratio of 8.12, a price-to-earnings-growth ratio of 1.07 and a beta of 0.81. The company has a 50-day simple moving average of $73.96 and a 200 day simple moving average of $63.76. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 0.32.

Unum Group (NYSE:UNM) last posted its quarterly earnings data on Tuesday, October 29th. The financial services provider reported $2.13 earnings per share for the quarter, topping the consensus estimate of $2.10 by $0.03. The company had revenue of $3.22 billion during the quarter, compared to analyst estimates of $3.26 billion. Unum Group had a net margin of 13.76% and a return on equity of 15.21%. The company’s revenue was up 4.0% on a year-over-year basis. During the same quarter last year, the business posted $1.94 earnings per share. Research analysts expect that Unum Group will post 8.54 earnings per share for the current fiscal year.

Unum Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Friday, January 24th will be issued a dividend of $0.42 per share. This represents a $1.68 annualized dividend and a dividend yield of 2.24%. The ex-dividend date of this dividend is Friday, January 24th. Unum Group’s payout ratio is presently 18.18%.

Unum Group Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.